I believe India is great for manufacturing generics (not the Java/C# variants), although I don't believe they can export them to US, even if India was innovative in this area I think export controls, lobbying and patents would hinder any disruption to US - you'll be paying $200 a course of antibotics that would cost $0.50 elsewhere for a very long time. If I was non-critically sick in America and without insurance (or even with where you pay X%), I'd do a rough calculation to see if it was cheaper to fly business class to India and go straight to a private hospital.